ACTRN12621000024842已完成未知
Seroconversion with Japanese encephalitis vaccine via intradermal route in healthy individuals
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 51
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- All
入选标准
- •Able to give written informed consent after all aspects of the protocol have been explained.
- •Between 18 and 45 years of age.
- •No prior history of Japanese encephalitis vaccination.
- •No serious uncontrolled medical conditions (as determined by a travel medicine doctor).
排除标准
- •Previous Japanese encephalitis vaccine.
- •Previous dengue and/or yellow fever vaccine, or planning to have any of these vaccines during the next two months.
- •Live vaccine in the month prior, or planning to have during the next two months.
- •Contraindication for Japanese encephalitis vaccine.
- •Contraindication for live vaccines.
- •History of dengue fever.
- •Taking medications (e.g. TNF inhibitors, methotrexate, or steroids) or medical conditions that impair the normal functioning of the immune system.
- •Pregnancy or planning pregnancy.
- •Breastfeeding.
- •Lived in Japanese encephalitis risk area for more than a year.
- •Travelling or planning to travel to areas of high risk for Japanese encephalitis within the next two months.
研究者
相似试验
招募中
3 期
Immunogenicity and safety of the Japanese encephalitis vaccine given intradermally in children and adultsACTRN12623000214639Sydney Children's Hospital Network900
尚未招募
3 期
ong Term Immunogenicity of the JE Vaccine IC51Prophylactic Vaccine against Japanese EncephalitisNeurological - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12605000681651Intercell AG600
已完成
不适用
Antibody response after vaccination with Japanese Hepatitis A Vaccine and evaluation of the booster programHepatitis AJPRN-UMIN000013624Tokyo Medical University30
已完成
3 期
Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese ToddlersJapanese EncephalitisMeaslesRubellaMumpsNCT01188343Sanofi Pasteur, a Sanofi Company542
进行中（未招募）
不适用
Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic CountriesJapanese Encephalitis (JE)MedDRA version: 13.1Level: PTClassification code 10014596Term: Encephalitis Japanese BSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 13.1Level: LLTClassification code 10023120Term: Japanese B viral encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 13.1Level: LLTClassification code 10023123Term: Japanese encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 13.1Level: LLTClassification code 10023122Term: Japanese B virus encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 13.1Level: LLTClassification code 10023119Term: Japanese B encephalitisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2009-015595-10-SEIntercell AG100